Catalyst watch: Nio event, Ivanhoe Electric lockup expiration and Cal-Maine earnings
gorodenkoff

Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report.
Monday - December 26


Earnings watch -  U.S. stock markets are closed for observance of the Christmas holiday.

All day -  The weekend box office numbers for Avatar: The Way of Water will be closely watched after the first weekend fell short of Disney's (DIS) forecast. The movie's second week is expected to spotlight if the James Cameron film will have long-term box office appeal. It will also be a big weekend overall for theater stocks such as AMC Entertainment (AMC), IMAX (IMAX) and Cinemark (CNK) with the days between Christmas and New Year's Day typically accounting for as much as 5% of the year's total box office haul.

Tuesday - December 27


Volatility watch - Options trading volume has zoomed higher once again on AMC Entertainment (AMC). Short interest has reached a multi-month high on Beyond Meat (BYND). Also watch for swings with TC Energy (TRP) with the full Keystone pipeline restart scheduled for next week.

All day -  Nio (NIO) will be on watch following its annual Nio Day event over the weekend. The Chinese EV startup is expected to unveil two new models and a new power station product. Shares of Nio (NIO) have rallied sharply in the past after the event was well received.

All day -  The IPO lockup period expires for a block of shares of Ivanhoe Electric (IE). Shares of Ivanhoe have fallen 18% over the last week ahead of the lockup expiration.

All day -  Several SPAC deals will go to a shareholder vote. Watch for developments with Tailwind Acquisition's (TWND) deal to take laser maker Nuburu and Model Performance Acquisition's (MPAC) deal to take entertainment firm MultiMetaVerse public.

Wednesday - December 28


Earnings watch -  Cal-Maine Foods (CALM) will report earnings. The USDA just increased its forecast for egg prices for 2023 to a range of +4% to +5% after prices for eggs at retail locations has surged more than 30% this year. Cal-Maine has racked up a 67% year-to-date gain in part due to the pricing strength. Options trading is implying a share price swing of 8% after the new report drops.

All day -  Clinical-stage biotech TG Therapeutics (TGTX) will be on watch on the action date for the company s Biologics License Application for ublituximab for relapsing forms of multiple sclerosis. Shares soared more than 50% in November after Chief Executive Michael Weiss said that the company has started labeling discussions with the FDA ahead of a potential U.S. approval for the therapy.

Thursday - December 29


All day -  Roche (OTCQX:RHHBY) (OTCQX:RHHBF) could see some action with the FDA expected to make a decision on mosunetuzumab for relapsed or refractory follicular lymphoma. The biologic received conditional marketing in Europe in August under the name Lunsumio. If approved in the U.S., mosunetuzumab would become the first bispecific antibody approved for non-Hodgkin's lymphoma.

Friday - December 30


All day -  It is the last trading day of the year, which can have portfolio rebalancing implications for certain stocks.

All day -  Netflix (NFLX) members will be able to stream fitness content from Nike (NKE) Training Club for the first time ever in a partnership seen benefiting both companies.

All day -  It is the walk date for the Sino-Biopharma (OTCPK:SBHMY) acquisition of F-star Therapeutics (FSTX), as well as the Rogers (RCI) deal to take over of Shaw Communications (SJR). Both walk dates could be extended.

All day -  The four-day San Diego Auto Show begins with a media event. Some of the automakers showing off new models include Hyundai (OTCPK:HYMLF), Nissan (OTCPK:NSANY), Stellantis' (STLA) with the Ram and Jeep brands, Ford (F), and Volkswagen (OTCPK:VLKAF). Analysts will be watching the auto show closely for clues on pricing and incentives on 2023 models.